Methods, devices, and kits for microjet drug delivery

• US 20080091139A1
• Filed: 06/19/2007
• Published: 04/17/2008
• Est. Priority Date: 06/19/2006
• Status: Active Grant

• Current Assignee: Corium Pharma Solutions, Inc.
• Original Assignee: Corium International, Inc.
• Inventors: Urso, Richard, Pistor, Christoph, Yogi, Takashi, Kantak, Ameya, Srinivasan, Ravi
• Granted Patent: US 9,308,325 B2
• Time in Patent Office: Days
• US Class Current: 604/68
• CPC Class Codes: A61M 2005/3022 Worn on the body, e.g. as patches pressure infusion of the skin patch type A61M5/14248
• CPC Class Codes: A61M 5/2053 Media being expelled from injector by pressurised fluid or vacuum for infusion A61M5/145, A61M5/155
• CPC Class Codes: A61M 5/30 Syringes for injection by jet action, without needle, e.g. for use with replaceable ampoules or carpules

Abstract

Described here are methods, devices, and kits for microjet drug delivery. The devices described here may be modular or non-modular. The modular devices typically include a first module having a drug reservoir and a nozzle in fluid communication with the drug reservoir and a second module having an actuator and a power supply. The power supply provides power to the actuator and when the first and second modules are coupled, the actuator is capable of acting on a dispensing member causing it to dispense a drug in liquid form from the drug reservoir via the nozzle at a velocity sufficient to penetrate skin. Other devices described include a nozzle, a reservoir in fluid communication with the nozzle, a dispensing member, and an actuator. In these devices, the nozzle has at least one feature that enhances nozzle contact with the skin in order to reduce lateral drug leakage about the nozzle.

Claims

1. A modular drug delivery device comprising:

a first module comprising a drug reservoir and a nozzle in fluid communication with the drug reservoir; and

a second module comprising an actuator and a power supply, wherein the power supply provides power to the actuator and wherein the first and second modules are capable of being releasably coupled to form a modular drug delivery device, and wherein when the first and second modules are coupled, the actuator is capable of acting on a dispensing member causing it to dispense a drug in liquid form from the nozzle at a velocity sufficient to penetrate skin.

2. The modular drug delivery device of claim 1, wherein the actuator is selected from the group consisting of a piezoelectric actuator, a spring, a solenoid, a magnet, a motor, and a compressed gas actuator.

3. The modular drug delivery device of claim 2, wherein the actuator is a piezoelectric actuator.

4. The modular drug delivery device of claim 1, wherein the dispensing member is a plunger.

5. The modular drug delivery device of claim 4, wherein the plunger has one or more grooves thereon.

6. The modular drug delivery device of claim 1, wherein the reservoir is refillable.

7. The modular drug delivery device of claim 1, wherein the reservoir contains a pre-filled amount of drug and is configured for a single-use.

8. The modular drug delivery device of claim 1, wherein the device is programmable.

9. The modular drug delivery device of claim 1, wherein at least a portion of the device is made of a hydrophilic material or is coated with a hydrophilic agent.

10. The modular drug delivery device of claim 1, further comprising a locking mechanism to temporarily lock the first and second modules together.

11. The modular drug delivery device of claim 1, wherein the first module has a basal surface and a top surface and further comprises an adhesive on at least a portion of its basal surface to provide for temporary device attachment to the skin.

12. The modular drug delivery device of claim 3, wherein the piezoelectric actuator is controlled by one or more switches that are operated to apply a voltage pulse to the piezoelectric actuator.

13. The modular drug delivery device of claim 1, wherein the power supply is a battery.

14. The modular drug delivery device of claim 13, wherein the battery is a rechargeable battery.

15. The modular drug delivery device of claim 1, wherein the second module further comprises a field programmable gate array.

16. The modular drug delivery device of claim 1 further comprising a display.

17. The modular drug delivery device of claim 1 further comprising at least one LED.

18. The modular drug delivery device of claim 1 further comprising at least one element to reduce leakage of drug around the dispensing member.

19. The modular drug delivery device of claim 18 wherein the at least one element to reduce leakage of drug around the dispensing member comprises a diaphragm coupled to the dispensing member.

20. The modular drug delivery device of claim 19 further comprising at least one retaining ring, wherein at least a portion of the diaphragm is coupled with the retaining ring.

21. The modular drug delivery device of claim 19 further comprising at least one elastomeric sealing member.

22. The modular drug delivery device of claim 1 wherein the second module further comprises a user interface switch.

23. The modular drug delivery device of claim 1 wherein the first module is configured for a single-use.

24. The modular drug delivery device of claim 1 wherein the first and second modules are uniquely mateable for a given therapy.

25. The modular drug delivery device of claim 1 wherein the first module comprises more than one nozzle.

26. The modular drug delivery device of claim 1 wherein the nozzle has a variable diameter at its distal opening.

27. The modular drug delivery device of claim 1 wherein the nozzle is an interchangeable nozzle.

28. A microjet drug delivery device for needleless drug delivery across a skin surface comprising:

a nozzle;

a drug reservoir in fluid communication with the nozzle;

a dispensing member; and

an actuator, wherein the actuator is configured to act on the dispensing member causing it to dispense an amount of drug in liquid form from the nozzle at a velocity sufficient to penetrate skin, and wherein the device comprises at least one feature that reduces leakage of the drug.

29. The microjet device of claim 28, wherein at least a portion of the device has a geometry that enhances nozzle contact with skin in order to reduce lateral leakage of drug.

30. The microjet device of claim 28, further comprising a flange disposed about at least a portion of the dispensing member.

31. The microjet device of claim 28, wherein the dispensing member is a plunger.

32. The microjet device of claim 28, wherein the at least one element to reduce leakage of drug is configured to reduce leakage around the dispensing member.

33. The microjet device of claim 28, wherein at least a portion of the device adjacent the nozzle has a plurality of concentric rings formed at least partially thereon.

34. The microjet device of claim 28, further comprising at least two electrodes to measure capacitance of the skin.

35. The microjet device of claim 28, wherein the actuator is selected from the group consisting of a piezoelectric actuator, a spring, a motor, a solenoid, a magnet, and a compressed gas actuator.

36. The microjet device of claim 35, wherein the actuator is a piezoelectric actuator.

37. The microjet device of claim 28, wherein the device is programmable.

38. The microjet device of claim 28, wherein the device has a basal surface and a top surface and further comprises an adhesive on at least a portion of the basal surface to provide for temporary device attachment to skin.

39. The microjet device of claim 36, further comprising at least one noise-reduction element that is capable of reducing the sound generated by the piezoelectric actuator.

40. The microjet device of claim 39 wherein the at least one noise-reduction element is selected from the group consisting of acoustic foam, sound absorbing silicone, acoustic rubber, a suspension of micro hollow glass spheres, and a combination thereof.

41. The microjet device of claim 28, wherein a portion of the device is made of a hydrophilic material or is coated with a hydrophilic agent.

42. The microjet device of claim 28, wherein the reservoir is refillable.

43. The microjet device of claim 28, wherein the reservoir contains a pre-filled amount of drug and is configured for a single-use.

44. The microjet device of claim 28, further comprising a flow restrictor that governs the refill flow rate to the nozzle from the reservoir after drug has been dispensed therefrom.

45. The microjet device of claim 44 wherein the flow restrictor comprises a fluidic channel having an inner diameter between about 10 and about 200 μ

m.

46. The microjet device of claim 28 wherein the amount of drug dispensed in a single dispensing action is between about 5 nL and about 10 nL.

47. The microjet device of claim 28 wherein at least a portion of the nozzle is made from a polymeric material.

48. The microjet device of claim 28 further comprising more than one nozzle.

49. The microjet device of claim 28 wherein the nozzle has a variable diameter at its distal opening.

50. The microjet device of claim 28 wherein the nozzle is an interchangeable nozzle.

51. A microjet drug delivery device for needleless drug delivery across a skin surface comprising:

a nozzle;

a drug reservoir in fluid communication with the nozzle;

a dispensing member; and

a piezoelectric actuator having an unexpanded state and an expanded stated and configured to act on the dispensing member when in the expanded state, causing it to dispense an amount of drug in liquid form from the nozzle at a velocity sufficient to penetrate skin, wherein the piezoelectric actuator is in electrical communication with a capacitor and at least one switch.

52. The microjet drug delivery device of claim 51 wherein the capacitor has a capacitance that is about 1.5 to about 10 times the capacitance of the piezoelectric actuator.

53. The microjet drug delivery device of claim 51 wherein the capacitor is charged to a voltage that is the same or higher than the desired final voltage of the piezoelectric actuator when it is in its expanded state.

54. The microjet drug delivery device of claim 51 wherein the switch is a solid state switch and is used at least to discharge the piezoelectric actuator to bring the piezoelectric actuator back to its unexpanded state.

55. The microjet drug delivery device of claim 51 further comprising more than one switch.

56. The microjet drug delivery device of claim 55 wherein the switches are not closed at the same time.

57. The microjet drug delivery device of claim 51 wherein the piezoelectric actuator is expanded within a specified rise-time, maintained in an expanded position for a specified dwell time, brought back to its unexpanded state within a specified fall time, and maintained in the unexpanded state for a specified time, forming a single cycle of operation.

58. The microjet drug delivery device of claim 51 further comprising a battery in electrical communication with the capacitor.

59. The microjet drug delivery device of claim 58 wherein the battery is selected from the group consisting of a lithium ion battery, a zinc-air battery, a lithium manganese oxide battery, a zinc manganese oxide battery, a lithium sulfuryl chloride battery, a lithium polymer battery, a lithium vanadium oxide battery, and a nickel metal hydride battery.

60. The microjet drug delivery device of claim 58 further comprising a DC upconversion module.

61. The microjet drug delivery device of claim 60 wherein the DC upconversion module comprises a switching mode power supply.

62. The microjet drug delivery device of claim 61 wherein the switching mode power supply is a boost converter.

63. The microjet drug delivery device of claim 60 wherein the DC upconversion module comprises a charge pump.

64. The microjet drug delivery device of claim 51 further comprising a microprocessor.

65. The microjet drug delivery device of claim 60 further comprising a microprocessor, where the microprocessor is configured to control the DC upconversion.